V záujme zachovania jednotnosti v nomenklatúre, uvádzame v tejto tabuľke názvy chorôb a plemien v anglickom jazyku.
Pes
Dedičné ochorenia psov
Breed | Genetic disease |
---|---|
Afghan Hound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC) |
Airedale Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Lethal lung disease (LAMP3), Faktor VII - deficiency, Protein losing nephropathy (PLN) |
Akita | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Amelogenesis imperfecta (AI) |
Alaskan Klee Kai | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Faktor VII - deficiency |
Alaskan Malamute | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Alaskan Malamute Polyneuropathy (AMPN), Primary ciliary dyskinesia (PCD) |
Alpine Dachsbracke | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Spinocerebellar ataxia (SCA) |
American Akita | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Amelogenesis imperfecta (AI), Hämophilia B (Faktor IX) |
American Bulldog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Canine multi-focal rethinopathy (CMR), Nemalin myopathy (NM), Ichthyosis, Robinow-like syndrome (DVL2) |
American Cocker Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Phosphofruktokinase-deficiency (PFKD), Exercise induced collapse (EIC), Macrothrombocytopenia (MTC), Gallbladder mucoceles |
American Eskimo Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Primary lens luxation (PLL) |
American Hairless Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
American Pitbull Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (crd2-PRA), Robinow-like syndrome (DVL2) |
American Staffordshire Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (crd1-PRA), Neuronal ceroid lipofuscinosis (NCL), Robinow-like syndrome (DVL2) |
Australian Cattle Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (rcd4-PRA), Primary lens luxation (PLL), Myotonia congenita, Cystinuria |
Australian Kelpie | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Collie eye anomaly (CEA) |
Australian Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Progressive retinal atrophy (prcd-PRA), Canine multi-focal rethinopathy (CMR), Hereditary cataract (HSF4), Brachyuria (stumpy-tail), Collie eye anomaly (CEA) , Hereditary ataxia (HA), MDR1 gene variant (Ivermectin hypersensitivity), Startle disease |
Australian Stumpy Tail Cattle Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), Progressive retinal atrophy (prcd-PRA) |
Austrian Pinscher | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Barbet | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
Barsoi | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC) |
Basenji | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (Bas-PRA1), Pyruvatkinase-deficiency (PK), Fanconi Syndrome |
Basset Fauve de Bretagne | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary open angle glaukoma (POAG) |
Basset Hound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Thrombopathia, Primary open angle glaukoma (POAG), Lafora disease, X-chromosomal severe combined immuno-deficiency (X-SCID) |
Beagle | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Musladin-Lueke syndrome (MLS), Primary open angle glaukoma (POAG), Imerslund-Gräsbeck syndrom (IGS), Pyruvatkinase-deficiency (PK), Faktor VII - deficiency, Neonatal cerebellar abiotrophy (NCCD), Actalasemia, Lafora disease, Progressive retinal atrophy (cord1-PRA), Osteogenesis imperfecta (brittle-bone-disease) |
Bearded Collie | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Collie eye anomaly (CEA) |
Beauceron | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hereditary deafness |
Bedlington Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Copper storage disease - Copper Toxicosis (CT) |
Belgian Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Spongi degeneration with cerebellar ataxia type 1 (SDCA1) Spongi degeneration with cerebellar ataxia type 2 (SDCA2), Cardiomyopathy with juvenile mortality (CJM), CNS atrophy with cerebellar ataxia (CACA), Behaviour propensity (Malinois) |
Berger Blank Suisse | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), MDR1 gene variant (Ivermectin hypersensitivity) |
Bernese Mountain Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Degenerative Myelopathy Exon 1 (DM Exon 1), von-Willebrand disease type 1 (vWD 1) |
Bichon Frise | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Macrothrombocytopenia (MTC) |
Black Russian Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Juvenile laryngeal paralysis & polyneuropathy (JLPP) |
Bobtail | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary ciliary dyskinesia (PCD), Exercise induced collapse (EIC), MDR1 gene variant (Ivermectin hypersensitivity) |
Boerboel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multi-focal rethinopathy (CMR) |
Bolognese | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
Bolonka Zwetna | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (cord1-PRA) |
Border Collie | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Glaucma and goniodysgenesis (GG), Trapped neutrophil syndrome (TNS), Imerslund-Gräsbeck syndrom (IGS), Collie eye anomaly (CEA) , Sensory neuropathy (SN), Raine syndrome, MDR1 gene variant (Ivermectin hypersensitivity) |
Border Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Spongiform leukoencephalomyelopathy (SLEM) |
Boston Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hereditary cataract (HSF4), Robinow-like syndrome (DVL2) |
Bouvier des Ardennes | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Bouvier des Flandres | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Exercise induced collapse (EIC) |
Boxer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hämophilia A (faktor VIII), Macrothrombocytopenia (MTC) |
Boykin Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Exercise induced collapse (EIC), Collie eye anomaly (CEA) |
Braque du Bourbonnais | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Brasilian Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Mucopolysaccharidosis type VII (MPS7), Brachyuria (stumpy-tail) |
Briard | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Congenital stationary night blindness (CSNB) |
Brittany Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), C3-deficiency (C3), Brachyuria (stumpy-tail) |
Bullmastiff | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (dom.-PRA), Canine multi-focal rethinopathy (CMR), Mitochondrial fission encephalopathy |
Bull Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Polycystic kidney disease (PKD), Lethal acrodermatitis (LAD), Laryngeal paralysis (LP) |
Cairn Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Globoid cell leukodystrophy (Krabbe-disease), Pyruvatkinase-deficiency (PK), Macrothrombocytopenia (MTC), Cranimandibular osteopathy (CMO), Gallbladder mucoceles |
Cardigan Welsh Corgi | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), Progressive retinal atrophy (rcd3-PRA), Lafora disease, X-chromosomal severe combined immuno-deficiency (X-SCID) |
Cavalier King Charles Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Dry eye curly coat syndrome (CCS), Episodic falling (EF), Macrothrombocytopenia (MTC), Muscular dystrophy (MD), Xanthinurie Typ II, MCAD deficiency |
Central Asian Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Dystrophic epidermolysis bullosa (DEB) |
Chesapeake Bay Retriever | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Exercise induced collapse (EIC), Ectodermal dysplasia/Skin fragility syndrome (ED/SFS) |
Chihuahua | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Macrothrombocytopenia (MTC), Neuronal ceroid lipofuscinosis (NCL), Lafora disease |
Chinese Crested Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multiple system degeneration (CMSD), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (rcd3-PRA), Primary lens luxation (PLL), Neuronal ceroid lipofuscinosis (NCL) |
Chinook | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Chondrodysplasia (Dwarfism) |
Chow Chow | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC) |
Clumber Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Pyruvat dehydrogenase phosphatase 1 deficiency (PDP1), Exercise induced collapse (EIC), Progressive retinal atrophy (cord1-PRA) |
Collie (rough and smooth) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Grey Collie syndrome (canine zyclic neutropenia), Progressive retinal atrophy (rcd2-PRA), Collie eye anomaly (CEA) , Inflammatory pulmonary disease (IPD), Dermatomyositis (DMS), MDR1 gene variant (Ivermectin hypersensitivity) |
Continental Bulldog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Cystinuria, Robinow-like syndrome |
Coton de Tuléar | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1), Canine multi-focal rethinopathy (CMR), Primary Hyperoxaluria (PH) |
Croatian Sheepdog (Hrvatski ovčar) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Curly Coated Retriever | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Glycogen storage disease (GSD IIIa), Exercise induced collapse (EIC), Progressive retinal atrophy (cord1-PRA) |
Dachshund (Dackel) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Progressive retinal atrophy (crd-PRA), Progressive retinal atrophy (cord1-PRA), Lafora disease, Narcolepsy, Osteogenesis imperfecta (brittle-bone-disease), Color dilution and neurological defects, Mucopolysaccharidosis type IIIa (MPS3a), Afibrinogenemia (AFG), Xanthinurie Typ II |
Dalmatian | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Acute respiratory distress syndrome (ARDS) |
Danish-Swedish Farmdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), Primary lens luxation (PLL) |
Deerhound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Faktor VII - deficiency |
Dobermann | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1), Hereditary deafness, Narcolepsy, Copper storage disease - Copper Toxicosis, Dilated cardiomyopathy DCM1, Dilated cardiomyopathy DCM2 |
Dogo Argentino | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Disproportionate dwarfism |
Dogue de Bordeaux | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Digital hyperkeratosis (DH/HFH), Canine multi-focal rethinopathy (CMR), Robinow-like syndrome (DVL2) |
Drentse Patrijshond | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1) |
Dutch Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Spongi degeneration with cerebellar ataxia type 1 (SDCA1) Spongi degeneration with cerebellar ataxia type 2 (SDCA2), Inflammatory myopathy (IM) |
Elo | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), MDR1 gene variant (Ivermectin hypersensitivity) |
English Bulldog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multi-focal rethinopathy (CMR), Cystinuria, Robinow-like syndrome (DVL2) |
English Cocker Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Familial nephropathy (FN), Progressive retinal atrophy (prcd-PRA), Exercise induced collapse (EIC), Macrothrombocytopenia (MTC), Gallbladder mucoceles, Acral mutilation syndrome (AMS), Xanthinurie Typ II |
English Pointer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Acral mutilation syndrome (AMS) |
English Setter | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Progressive retinal atrophy (rcd4-PRA) |
English Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
English Springer Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Phosphofructokinase-deficiency (PFKD), Familial nephropathy (FN), Hypomyelination (Shaking Puppy Syndrome), Progressive retinal atrophy (cord1-PRA), Fucosidosis, Acral mutilation syndrome (AMS), Dyserythropoietic anemia and myopathy (DAMS) |
English Toy Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Xanthinurie Typ II |
Entlebucher Mountain Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
Eurasian | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Dandy-Walker-Like malformation (DWLM) |
Field Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Adult onset neuropathy (AON) |
Finnish Hound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Finnish hound ataxia (FHA), Faktor VII - deficiency |
Finnish Lapphund | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Glycogen storage disease Type II (Pompe) (GSD II), Progressive retinal atrophy (prcd-PRA) |
Flatcoated Retriever | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Obesity |
Fox Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Spinocerebellar ataxia (SCA), Congenital Hypothyreosis (CHG), van den Ende-Gupta syndrome (VDEGS) |
French Bulldog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Congenital Hypothyreosis (CHG), Hereditary cataract (HSF4), Canine multi-focal rethinopathy (CMR), Cystinuria, Lafora disease, Robinow-like syndrome (DVL2) |
French Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Acral mutilation syndrome (AMS) |
Frisian Water Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Severe combined immuno deficiency (SCID) |
Galgo Espanol | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Startle-disease |
German Hunting Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Centronuclear myopathy (CNM) |
German Pinscher | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1), Glycogen storage disease type Ia (GSD Ia) |
German Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Mucopolysaccharidosis type VII (MPS7), Achromatopsia (Day blindness) (ACHM), MDR1 gene variant (Ivermectin hypersensitivity), Hemorragic diathesis (Scott Syndrom), Hämophilia A (faktor VIII), Leukocyte adhesion deficiency III (LAD III), Pituitary dwarfism, Renal Cystadenocarcinoma and nodular dermatofibrosis (RCND), Congenital idiopathic megaesophagus (CIM) |
German Short-haired Pointing Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Junctional epidermolysis bullosa (JEB), von-Willebrand disease type 2 (vWD 2), Acral mutilation syndrome (AMS), Cone Degeneration (CD), Exfoliative cutaneous lupus erythematosus (ECLE) |
German Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Phosphofructokinase-deficiency (PFKD), |
German Spitz | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
German Wirehaired Pointer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 2 (vWD 2), Exercise induced collapse (EIC) |
Giant Schnauzer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Faktor VII - deficiency, Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (NECAP1-PRA), Dilated cardiomyopathy (DCM) |
Golden Retriever | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (GR-PRA1), Progressive retinal atrophy (GR-PRA2), Progressive retinal atrophy (prcd-PRA), Congenital myasthenic syndrome (CMS), Neuronal ceroid lipofuscinosis (NCL), Muscular dystrophy (MD), Ichthyosis, Osteogenesis imperfecta (brittle-bone-disease), Ichthyosis type 2 |
Gordon Setter | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hereditary ataxia (HA), Progressive retinal atrophy (rcd4-PRA), Neuronal ceroid lipofuscinosis (NCL) |
Great Dane | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Congenital Ichthyosis, Leukoencephalomyelopathy (LEMP), Centronuclear myopathy (CNM) |
Great Pyrenee | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multi-focal rethinopathy (CMR) |
Great Swiss Mountain Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Postoperative hemorrhage (P2Y12) |
Greyhound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Greyhound neuropathy (GHN), Hereditary nasal parakeratosis (HNPK) |
Havanese | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hämophilia A (faktor VIII), Macrothrombocytopenia (MTC) |
Hovawart | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hämophilia B (Faktor IX) |
Husky | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Alaskan Husky Encephalopathy (AHE), Progressive retinal atrophy (XL-PRA), Warburg Micro Syndrome 1 (WARBM1), GM1-gangliosidosis |
Irish Glen of Imaal Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (crd3-PRA) |
Irish Red and White Setter | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine leukozyte adhesion deficiency (CLAD), Progressive retinal atrophy (rcd1-PRA), Progressive retinal atrophy (rcd4-PRA), von-Willebrand disease type 1 (vWD 1) |
Irish Red Setter | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine leukozyte adhesion deficiency (CLAD), Progressive retinal atrophy (rcd1-PRA), Globoid cell leukodystrophy (Krabbe-disease), Progressive retinal atrophy (rcd4-PRA), von-Willebrand disease type 1 (vWD 1) |
Irish Soft-Coated Wheaten Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Protein losing nephropathy (PLN), Paroxysmal dyskinesia (PxD), Microphthalmia (RBP4) von-Willebrand disease type 1 (vWD 1) |
Irish Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Digital hyperkeratosis (DH/HFH) |
Irish Wolfhound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Startle-disease |
Italian Cane Corso | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multi-focal rethinopathy (CMR), Neuronal ceroid lipofuscinosis (NCL), Dental-skeletal-retinal anomaly (DSRA) |
Italian Greyhound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Amelogenesis imperfecta (AI) |
Italian Spinone | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Cerebellar ataxia (CA) |
Jack Russell Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Spinocerebellar ataxia (SCA), Late onset ataxia (LOA), Congenital myasthenic syndrome (CMS), Primary lens luxation (PLL), Macrothrombocytopenia (MTC), Brachyuria (stumpy-tail), Juvenile brain disease (JBD), Severe combined immuno deficiency (SCID) |
Japanese Chin | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), GM2-Gangliosidosis |
Karelian Bear Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), Progressive retinal atrophy (prcd-PRA), Chondrodysplasia (Dwarfism), Hypophosphatasia (HPP), Pituitary dwarfism |
Keeshond | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC) |
Kerry Blue Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multiple system degeneration (CMSD), von-Willebrand disease type 1 (vWD 1), Factor XI deficiency (F11) |
Komondor | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Imerslund-Gräsbeck syndrom (IGS) |
Kooikerhondje | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 3 (vWD 3) |
Kromfohrländer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Digital hyperkeratosis (DH/HFH), von-Willebrand disease type 1 (vWD 1) |
Kuvasz | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
Labrador Retriever | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Hereditary nasal parakeratosis (HNPK), Exercise induced collapse (EIC), Pyruvatkinase-deficiency (PK), Centronuclear myopathy (CNM), Skeletal dysplasia 2 (SD 2), Retinal dysplasia (OSD), Achromatopsia (Day blindness) (ACHM), Congenital myasthenic syndrome (CMS), Macrothrombocytopenia (MTC), X-linked Myopathy (XL-MTM), Alexander disease (AxD), Obesity, Cystinuria, Narcolepsy, Myotonia congenita, Stargardt disease (STGD, retinal degeneration), Copper storage disease - Copper Toxicosis, Laryngeal paralysis with polyneuropathy type 3 (LPPN3), Macular corneal dystrophy (MCD), Dyserythropoietic anemia and myopathy (DAMS) |
Lagotto Romagnolo | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Lagotto storage disease (LSD), Juvenile epilepsy (JE), Progressive retinal atrophy (prcd-PRA), Neuroaxonal dystrophy (NAD) |
Lakeland Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Lancashire Heeler | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Collie eye anomaly (CEA) , Primary lens luxation (PLL) |
Landseer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Cystinuria, Muscular dystrophy (MD), Thrombopathia |
Lapponian Herder | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Glycogen storage disease type II (Pompe) (GSD II), Progressive retinal atrophy (prcd-PRA), Canine multi-focal rethinopathy (CMR), Pituitary dwarfism, Progressive retinal atrophy (IFT122-PRA) |
Large Münsterländer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC) |
Leonberger | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Leonberger polyneuropathy 1 (LPN1), Leonberger polyneuropathy 2 (LPN2), Leukoencephalomyelopathy (LEMP), Laryngeal paralysis with polyneuropathy type 3 (LPPN3) |
Lhasa Apso | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (PRA4), Hämophilia B (Faktor IX) |
Lucas Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Magyar Viszla | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neonatal cerebellar abiotrophy (NCCD), Exfoliative cutaneous lupus erythematosus (ECLE) |
Maltese | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Glycogen storage disease type Ia (GSD Ia), Macrothrombocytopenia (MTC) |
Manchester Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1), Xanthinurie Typ II |
Markiesje | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
Mastiff | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (dom.-PRA), Canine multi-focal rethinopathy (CMR), Cystinuria |
McNab | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), MDR1 gene variant (Ivermectin hypersensitivity) |
Miniature American Shepherd | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Progressive retinal atrophy (prcd-PRA), Canine multi-focal rethinopathy (CMR), Hereditary cataract (HSF4), Brachyuria (stumpy-tail), Collie eye anomaly (CEA) , Hereditary ataxia (HA), MDR1 gene variant (Ivermectin hypersensitivity), Startle disease |
Miniature Bull Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Lethal acrodermatitis (LAD), Laryngeal paralysis (LP) |
Miniature Pinscher | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Mucopolysaccharidosis type VI (MPS6), Cystinuria |
Miniature Poodle | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (rcd4-PRA), von-Willebrand disease type 1 (vWD 1) |
Miniature Schnauzer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Persistent Müllerian duct syndrome (PMDS), Myotonia congenita, Progressive retinal atrophy (type B1-PRA, HIVEP3), Spondylocostal Dysostosis (Comma Defect), Mycobacterium avium complex sensitivity (MAC), Charcot-Marie-Tooth Neuropathy (CMT) |
Mudi | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Newfoundland | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Cystinuria, Lafora disease |
Newzealand Huntaway | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Mucopolysaccharidosis type IIIa (MPS3a) |
Norfolk Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Epidermolytic hyperkeratosis (EHK), Muscular dystrophy (MD), Macrothrombocytopenia (MTC) |
Norrbottenspitz | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Finnish hound ataxia (FHA) |
Northern Inuit | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Retinal dysplasia (OSD) |
Norwegian Buhund | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hereditary ataxia (HA) |
Norwegian Elkhound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Primary open angle glaukoma (POAG), Chondrodysplasia (Dwarfism), Hereditary ataxia (HA) |
Norwegian Lundehund | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Lundehund syndrome (LHS) |
Norwich Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Renal dysplasia and hepatic fibrosis (RDHN), Upper airway syndrome (UAS) |
Nova Scotia Duck Tolling Retriever | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Collie eye anomaly (CEA) , Cleft lip/palate and syndactyly (CLPS), Cerebellar degeneration and myositis complex |
Old Danish Pointing Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Congenital myasthenic syndrome (CMS), Progressive retinal atrophy (rcd4-PRA) |
Olde English Bulldog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Cystinuria, Robinow-like syndrome (DVL2) |
Old English Sheepdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary ciliary dyskinesia (PCD), Exercise induced collapse (EIC), Hereditary ataxia (HA), Hämophilia A (faktor VIII), MDR1 gene variant (Ivermectin hypersensitivity) |
Papillon | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (pap-PRA1), von-Willebrand disease type 1 (vWD 1) Neuroaxonal dystrophy (NAD), Faktor VII - deficiency |
Parson Russell Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Spinocerebellar ataxia (SCA), Late onset ataxia (LOA), Congenital myasthenic syndrome (CMS), Primary lens luxation (PLL), Macrothrombocytopenia (MTC), Brachyuria (stumpy-tail), Juvenile brain disease (JBD), Severe combined immuno deficiency (SCID), Amelogenesis imperfecta (AI) |
Patterdale Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Spinocerebellar ataxia (SCA) |
Pembroke Welsh Corgi | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), von-Willebrand disease type 1 (vWD 1), Exercise induced collapse (EIC), Lafora disease, X-chromosomal severe combined immuno-deficiency (X-SCID) |
Perro de Presa Canario | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multi-focal rethinopathy (CMR) |
Petit Basset Griffon Vendeen | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary open angle glaukoma (POAG) |
Phalène | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (pap-PRA1) |
Polish Lowland Sheepdog (PON) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), Progressive retinal atrophy (rcd4-PRA) |
Pomeranian | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (rcd3-PRA), Vitamin-D dependent rickets (VDR), Gallbladder mucoceles |
Portuguese Water Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy early onset (eo-PRA), Progressive retinal atrophy (prcd-PRA), GM1-Gangliosidosis, Improper Coat |
Pug Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Pyruvatkinase-deficiency (PK), Pug dog encephalitis (PDE), Primary lens luxation (PLL), May-Hegglin anomaly (MHA) |
Puli | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Bardet-Biedl-syndrome (BBS) |
Pyrenean Mountain Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Canine multi-focal rethinopathy (CMR), Glanzmann Thrombastenia (GT) |
Pyrenean Sheepdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Rat Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Congenital Hypothyreosis (CHG) |
Rhodesian Ridgeback | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Juvenile myoclonic epilepsy (JME), Hämophilia B (Faktor IX), Hämophilia A (faktor VIII), Ventricular Arrhythmia , Hereditary deafness (EOAD) |
Rottweiler | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Juvenile laryngeal paralysis & polyneuropathy (JLPP), X-linked Myopathy (XL-MTM), Leukoencephalomyelopathy (LEMP), Neuroaxonal dystrophy (NAD), Hereditary deafness |
Saarloos Wolfdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Pituitary dwarfism |
Saluki | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Succinic semialdehyde dehydrogenase deficiency (SSADHD) |
Samoyed | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Familial nephropathy (FN), Progressive retinal atrophy (XL-PRA), Amelogenesis imperfecta / Familial enamel hypoplasia (FEH) |
Savoy Sheepdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Schapendoes | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (g-PRA) |
Schipperke | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail), Progressive retinal atrophy (prcd-PRA), Mucopolysaccharidosis type IIIb (MPS3b) |
Schnauzer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Dilated cardiomyopathy (DCM), Leukoencephalopathy (LEP) |
Scottish Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 3 (vWD 3), Cranimandibular osteopathy (CMO) |
Sealyham Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Shar Pei | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Shar Pei autoinflammatory disease (SPAID), Primary open angle glaukoma and lens luxation (POAG/PLL) |
Shetland Sheepdog (Sheltie) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 3 (vWD 3), Collie eye anomaly (CEA) , Dermatomyositis (DMS), Gallbladder mucoceles, Progressive retinal atrophy (CNGA1-PRA), Paroxysmal exercise-induced dyskinesia (PED), MDR1 gene variant (Ivermectin hypersensitivity), Progressive retinal atrophy (BBS2-PRA), Maxillary canine tooth mesioversion (MCM) |
Shiba Inu | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), GM1-Gangliosidosis, GM2-Gangliosidosis |
Shih Tzu | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Prekallikrein deficiency (KLK), Macrothrombocytopenia (MTC), Robinow-like syndrome (DVL2), Progressive retinal atrophy (JPH2-PRA) |
Silken Windhound | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), MDR1 gene variant (Ivermectin hypersensitivity), Collie eye anomaly (CEA) |
Silken Windsprite (Long Haired-Whippet) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Myostatin-mutation (Bully-Whippet), Phosphofructokinase-deficiency (PFKD), Collie eye anomaly (CEA) , MDR1 gene variant (Ivermectin hypersensitivity) |
Silky Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA) |
Sloughi | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (rcd1a-PRA) |
Small Munsterlander | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (rcd4-PRA) |
Spanish Water Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Congenital Hypothyreosis (CHG), Progressive retinal atrophy (prcd-PRA), Neuroaxonal dystrophy (NAD), Brachyuria (stumpy-tail), Progressive retinal atrophy early onset (eo-PRA) |
Saint Bernard | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Laryngeal paralysis with polyneuropathy type 3 (LPPN3) |
Stabyhoun | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1), Cerebral dysfunction |
Staffordshire Bull Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), L-2-Hydroxy glutaric acid uria (L2HGA), Hereditary cataract (HSF4), Robinow-like syndrome (DVL2) |
Standard Poodle | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neonatal enzephalopathy with seizures (NEWS), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (rcd4-PRA), von-Willebrand disease type 1 (vWD 1), Macrothrombocytopenia (MTC) |
Sussex Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Pyruvat dehydrogenase phosphatase 1 deficiency (PDP1) |
Swedish Farmdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Swedish Lapphund | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Glycogen storage disease Type II (Pompe) (GSD II), Progressive retinal atrophy (prcd-PRA) |
Swedish Vallhund | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Brachyuria (stumpy-tail) |
Tamaskan | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Retinal dysplasia (OSD) |
Tatra Shepherd Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (rcd4-PRA) |
Teddy Roosevelt Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Tenterfield Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Congenital Hypothyreosis (CHG), Primary lens luxation (PLL), Spinocerebellar ataxia (SCA), Pituitary dwarfism |
Tibetan Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (PRA3) |
Tibetan Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Neuronal ceroid lipofuscinosis (NCL), Primary lens luxation (PLL), Progressive retinal atrophy (rcd4-PRA), Pituitary dwarfism Progressive retinal atrophy (PRA3) |
Toy Fox Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), van den Ende-Gupta syndrome (VDEGS) |
Toy Poodle | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Progressive retinal atrophy (prcd-PRA), Progressive retinal atrophy (rcd4-PRA), von-Willebrand disease type 1 (vWD 1), GM2-Gangliosidosis |
Tschechoslowakian Wolfdog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Pituitary dwarfism |
Volpino Italiano | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Wäller | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hereditary cataract (HSF4), Progressive retinal atrophy (prcd-PRA), MDR1 gene variant (Ivermectin hypersensitivity) |
Weimaraner | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hypomyelination (Shaking Puppy Syndrome) (SPS), Spinal dysraphism (NTD) |
Welsh Corgi (see Cardigan or Pembroke) | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), von-Willebrand disease type 1 (vWD 1), Progressive retinal atrophy (rcd3-PRA), Brachyuria (stumpy-tail), Lafora disease, X-chromosomal severe combined immuno-deficiency (X-SCID) |
Welsh Springer Spaniel | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Faktor VII - deficiency, Familial nephropathy (FN), Dilated cardiomyopathy (DCM) |
Welsh Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Westfalia Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL) |
Westhighland White Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Globoid cell leukodystrophy (Krabbe-disease), Cranimandibular osteopathy (CMO), Pyruvatkinase-deficiency (PK) |
Whippet | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Myostatin-mutation (Bully-Whippet), Phosphofructokinase-deficiency (PFKD), Collie eye anomaly (CEA) , MDR1 gene variant (Ivermectin hypersensitivity) |
White Swiss Shepherd Dog | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), MDR1 gene variant (Ivermectin hypersensitivity), Pituitary dwarfism |
Wire-Haired Pointing Griffon Korthals | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Hereditary cataract (HSF4) |
Wirehaired Slovakian Pointer | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC) |
Yorkshire Terrier | Malignant Hyperthermia (MH), Degenerative Myelopathy (DM), Chondrodysplasia (CDPA) and -dystrophy (CDDY and IVDD risk), Hyperuricosuria (SLC), Primary lens luxation (PLL), Progressive retinal atrophy (prcd-PRA), L-2-Hydroxy glutaric acid uria (L2HGA), Subacute necrotising encephalopathy (SNE) |
Mačka
Dedičné ochorenia mačiek
Breed | Genetic disease |
---|---|
Abyssinian | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Progressive retinal atrophy (rdy-PRA), Pyruvate kinase deficiency (PK) |
American Curl- / Wirehair | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA) |
Australian Mist | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Hypokalemia |
Balinese | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1) |
Bengal (Leopard cat) | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Progressive retinal atrophy (PRA-b), Pyruvate kinase deficiency (PK) |
Birman (Sacred cat of Burma) | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Mucopolysaccharidose Typ VI (MPS VI), Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA), Hypotrichose and short life expectancy |
British Shorthair (BSH) | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA), Skeletal dyplasia (SD), Autoimmune lymphoproliferative syndrome (ALPS) |
British Longhair (BLH) | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Burmese | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Gangliosidosis (GM2), Head-Defect, Hypokalemia |
Chartreux | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Colorpoint | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Cornish Rex | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Hypokalemia |
Devon Rex | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Hypokalemia, Congenital myasthenic syndrome (CMS) |
Domestic Longhair | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Pyruvate kinase deficiency (PK), Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Domestic Shorthair | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), Mucopolysaccharidose Typ VI (MPS VI), Pyruvate kinase deficiency (PK) |
Egyptian Mau | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Pyruvate kinase deficiency (PK) |
Exotic Shorthair | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Javanese | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1) |
Karthäuser | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Korat | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Gangliosidosis (GM1 ), Gangliosidosis (GM2 ) |
LaPerm | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Pyruvate kinase deficiency (PK) |
Maine Coon | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Hypertrophic cardiomyopathy (HCM), Spinal muscular atrophy (SMA), Pyruvate kinase deficiency (PK), Factor XI deficiency |
Munchkin | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA) |
Neva Masquerade | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Pyruvate kinase deficiency (PK) |
Norwegian Forest Cat | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Glycogen storage disease (GSD4), Pyruvate kinase deficiency (PK) |
Ocicat | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Progressive retinal atrophy (rdy-PRA), Mucopolysaccharidose Typ VI (MPS VI), Pyruvate kinase deficiency (PK), Gangliosidosis (GM1 ) |
Oriental Shorthair (OSH) | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1 ) |
Persian | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Alpha-Mannosidosis (AMD), Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Peterbald | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1 ) |
Ragdoll | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Hypertrophic cardiomyopathy (HCM), Mucopolysaccharidose Typ VI (MPS VI), Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Russian Blue | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Savannah | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Pyruvate kinase deficiency (PK) |
Scottish Fold | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA), Osteochondrodysplasia |
Seychellois | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1 ) |
Selkirk Rex | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Polyzystic kidney disease (PKD), Progressive retinal atrophy (pd-PRA) |
Siamese | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1), Primary congenital glaucoma (PCG) |
Sibirian | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Pyruvate kinase deficiency (PK) |
Singapura | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Pyruvate kinase deficiency (PK), Hypokalemia |
Somali | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Progressive retinal atrophy (rdy-PRA), Pyruvate kinase deficiency (PK) |
Sphynx | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Hypertrophic cardiomyopathy (HCM), Hypokalemia, Congenital myasthenic syndrome (CMS) |
Thai | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1) |
Tonkinese | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Progressive retinal atrophy (rdAc-PRA), Mucopolysaccharidose Typ VI (MPS VI), Gangliosidosis (GM1 ), Gangliosidosis (GM2), Head-Defect, Hypokalemia |
Turkish Van | MDR1-gene variant, Myotonia congenita, Cystinuria, Factor XII deficiency (F12), genetic blood group determination, Acrodermatitis enteropathica |
Turkish Angora | MDR1-gene variant, Myotonia congenita Cystinuria, Factor XII deficiency (F12), genetic blood group determination |
Kôň
Dedičné ochorenia koní
Breed | Genetic diseases |
---|---|
Akhal-Teke | Polysaccharid storage myopathie (PSSM), Naked foal syndrome (NFS) |
Appaloosa | Polysaccharid storage myopathie (PSSM), Equine malignant hyperthermia (EMH), Hereditary equine regional dermal asthenia (HERDA), Glycogen branching enzyme deficiency (GBED), Hyperkalemic periodic paralysis (HYPP), Androgen Insensitivity Syndrome (AIS), Warmblood Fragile Foal Syndrome (WFFS), Immune Mediated Myositis & MYH1 Myopathy (MYHM) |
Arabian Horse | Polysaccharid storage myopathie (PSSM), Severe combined immuno-deficiency (SCID), Lavender foal syndrome (LFS), Cerebellar abiotrophy (CA) |
Ardennes / Ardennais | Polysaccharid storage myopathie (PSSM) |
Barb Horse | Polysaccharid storage myopathie (PSSM) |
Belgian Horse | Polysaccharid storage myopathie (PSSM), Junctional epidermolysis bullosa (H-JEB), Ocular Squamous Cell Carcinoma (SCC) |
Black Forest Horse | Polysaccharid storage myopathie (PSSM) |
Breton Horse | Polysaccharid storage myopathie (PSSM) |
Comtois Horse | Polysaccharid storage myopathie (PSSM) |
Connemara Pony | Polysaccharid storage myopathie (PSSM), Connemara Pony Hoof Wall Separation Disease (HWSD) |
Criollo Horse | Polysaccharid storage myopathie (PSSM) |
Dales Pony | Polysaccharid storage myopathie (PSSM), Foal immunodeficency syndrome (FIS) |
Dartmoor Pony | Polysaccharid storage myopathie (PSSM) |
Exmoor Pony | Polysaccharid storage myopathie (PSSM) |
Fell Pony | Polysaccharid storage myopathie (PSSM), Foal immunodeficency syndrome (FIS) |
Freiberger | Polysaccharid storage myopathie (PSSM) |
Frisian Horse | Polysaccharid storage myopathie (PSSM), Hydrocephalus, Dwarfism |
Gypsy Horse | Polysaccharid storage myopathie (PSSM) |
Haflinger | Polysaccharid storage myopathie (PSSM), Ocular Squamous Cell Carcinoma (SCC), Warmblood Fragile Foal Syndrome (WFFS) |
Hucul Pony | Polysaccharid storage myopathie (PSSM) |
Icelandic Horse | Polysaccharid storage myopathie (PSSM) |
Irish Cob | Polysaccharid storage myopathie (PSSM) |
Konik | Polysaccharid storage myopathie (PSSM) |
Lewitzer | Polysaccharid storage myopathie (PSSM) |
Merens Horse | Polysaccharid storage myopathie (PSSM) |
Miniature Horse | Polysaccharid storage myopathie (PSSM), Dwarfism (ACAN, Chondrodysplasia) |
Mustang | Polysaccharid storage myopathie (PSSM), Warmblood Fragile Foal Syndrome (WFFS) |
New Forest Pony | Polysaccharid storage myopathie (PSSM), Congenital Myotonia |
Noriker | Polysaccharid storage myopathie (PSSM) |
Paint Horse | Polysaccharid storage myopathie (PSSM), Equine malignant hyperthermia (EMH), Hereditary equine regional dermal asthenia (HERDA), Glycogen branching enzyme deficiency (GBED), Hyperkalemic periodic paralysis (HYPP), Overo lethal white foal syndrome (OLWS) Warmblood Fragile Foal Syndrome (WFFS), Immune Mediated Myositis & MYH1 Myopathy (MYHM) |
Percheron | Polysaccharid storage myopathie (PSSM) |
Pony of the Americas (POA) | Polysaccharid storage myopathie (PSSM) |
Quater Horse | Polysaccharid storage myopathie (PSSM), Equine malignant hyperthermia (EMH), Hereditary equine regional dermal asthenia (HERDA), Glycogen branching enzyme deficiency (GBED), Hyperkalemic periodic paralysis (HYPP), Androgen Insensitivity Syndrome (AIS), Warmblood Fragile Foal Syndrome (WFFS), Immune Mediated Myositis & MYH1 Myopathy (MYHM) |
Rhenish German Coldblood | Polysaccharid storage myopathie (PSSM) |
Rocky Mountain Horse | Polysaccharid storage myopathie (PSSM) |
Shetland Pony | Polysaccharid storage myopathie (PSSM) Dwarfism (ACAN, Chondrodysplasia) |
Tinker Horse | Polysaccharid storage myopathie (PSSM) |
Thoroughbred | Polysaccharid storage myopathie (PSSM), Tractability, Idiopathic hypocalcemia |
Warmblood Horses | Polysaccharid storage myopathie (PSSM), Warmblood Fragile Foal Syndrome (WFFS) |